Ignite Creation Date:
2024-05-05 @ 11:59 AM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00200668
Status:
TERMINATED
Last Update Posted:
2008-06-09
First Post:
2005-09-12
Brief Title:
Comparison Between FDG-PET and MRI for the Assessment of Response to Intensive Chemotherapy in Multiple Myeloma Patients
Sponsor:
Nantes University Hospital
Organization:
Nantes University Hospital
Study Overview
Official Title:
None
Status:
TERMINATED
Status Verified Date:
2008-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Comparison between FDG-PET and MRI for the assessment of response to intensive chemotherapy in multiple myeloma patients
Detailed Description:
First whole body FDG-PET scan and MRI before the start of the treatment Second whole body FDG-PET scan and MRI after the end of the treatment On a basis of patient comparison between PET and MRI will be done tumoral site by site Sensitivity Specificity will be estimated for both techniques In case of discrepancy another imaging method or biopsy if easy to perform will be serve as standard of reference Kappa coefficients and Mc Nemar test will be performed to compare the two methods FDG fluorodeoxyglucose FLUCIS Schering-CisBio international
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None